Article

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials-04-01-2010
Volume0
Issue 0

Applied Clinical Trials Digital Edition - April 2010

eCLINICAL : Global Advantages with CTMS From EDC to ETMS The Upfront Cost Hurdle of EDC eDiaries: Earlier is Better SUBJECT RECRUITMENT : Recruitment Grows on the Internet Also in this issue : FDA Wants Better Science, Flawed EU Directive, BRIDG for Better Models, NICE Gets Bad Rap

External Link - article-821343.pdf

Download Issue PDF
Articles in this issue
Applied Clinical Trials Digital Edition - April 2010
i1-664664-1408640044331.jpg
Alzheimer's by Phase
i1-664666-1408640040610.jpg
The Deeper Data Debate
i4-664783-1408639941009.jpg
The Upfront Cost Hurdle of EDC
i1-664661-1408640052425.jpg
Regulatory Science to Inform Trial Design
Data Integration in the Age of Global Trials
Data Integration in the Age of Global Trials

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Biogen, Stoke Therapeutics Launch Phase III Trial of Investigational Antisense Therapy for Dravet Syndrome
August 12th 2025

Biogen, Stoke Therapeutics Launch Phase III Trial of Investigational Antisense Therapy for Dravet Syndrome

Don Tracy, Associate Editor
ACT Brief Episode 2: FDA Oversight, Vaccine Funding Cuts, and the Digital Future of Clinical Trials
August 12th 2025

ACT Brief Episode 2: FDA Oversight, Vaccine Funding Cuts, and the Digital Future of Clinical Trials

Andy Studna, Senior Editor
Genmab’s Epkinly Shows Major Survival Benefit in Relapsed, Refractory Follicular Lymphoma
August 12th 2025

Genmab’s Epkinly Shows Major Survival Benefit in Relapsed, Refractory Follicular Lymphoma

Don Tracy, Associate Editor
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 12th 2025

ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials

Applied Clinical Trials Editorial Staff
Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss
August 12th 2025

Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss

Don Tracy, Associate Editor
© Satjawat - © Satjawat - stock.adobe.com
August 12th 2025

Tegoprazan Shows Superior Maintenance of Healing in Phase III TRIUMpH Study of Gastroesophageal Reflux Disease

Andy Studna, Senior Editor
© 2025 MJH Life Sciences

All rights reserved.